Health-related quality of life following percutaneous coronary intervention during the COVID-19 pandemic. 2022

Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
Department of Cardiology, Royal Melbourne Hospital, Melbourne, VIC, Australia.

OBJECTIVE During the COVID-19 pandemic, widespread public health measures were implemented to control community transmission. The association between these measures and health-related quality of life (HRQOL) among patients following percutaneous coronary intervention has not been studied. METHODS We included consecutive patients undergoing percutaneous coronary intervention (PCI) in the state-wide Victorian Cardiac Outcomes Registry between 1/3/2020 and 30/9/2020 (COVID-19 period; n = 5024), with a historical control group from the identical period one year prior (control period; n = 5041). HRQOL assessment was performed via telephone follow-up 30 days following PCI using the 3-level EQ-5D questionnaire and Australian-specific index values. RESULTS Baseline characteristics were similar between groups, but during the COVID-19 period indication for PCI was more common for acute coronary syndromes. No patients undergoing PCI were infected with COVID-19 at the time of their procedure. EQ-5D visual analogue score (VAS), index score, and individual components were higher at 30 days following PCI during the COVID-19 period (all P < 0.01). In multivariable analysis, the COVID-19 period was independently associated with higher VAS and index scores. No differences were observed between regions or stage of restrictions in categorical analysis. Similarly, in subgroup analysis, no significant interactions were observed. CONCLUSIONS Measures of HRQOL following PCI were higher during the COVID-19 pandemic compared to the previous year. These data suggest that challenging community circumstances may not always be associated with poor patient quality of life.

UI MeSH Term Description Entries
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D001315 Australia The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra. Canton and Enderbury Islands,Christmas Island,Christmas Island (Australia)
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic
D062645 Percutaneous Coronary Intervention A family of percutaneous techniques that are used to manage CORONARY OCCLUSION, including standard balloon angioplasty (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY), the placement of intracoronary STENTS, and atheroablative technologies (e.g., ATHERECTOMY; ENDARTERECTOMY; THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY). PTCA was the dominant form of PCI, before the widespread use of stenting. Percutaneous Coronary Revascularization,Coronary Intervention, Percutaneous,Coronary Interventions, Percutaneous,Coronary Revascularization, Percutaneous,Coronary Revascularizations, Percutaneous,Intervention, Percutaneous Coronary,Interventions, Percutaneous Coronary,Percutaneous Coronary Interventions,Percutaneous Coronary Revascularizations,Revascularization, Percutaneous Coronary,Revascularizations, Percutaneous Coronary

Related Publications

Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
June 2023, Cardiovascular revascularization medicine : including molecular interventions,
Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
July 2024, Archives of gerontology and geriatrics,
Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
January 2020, PloS one,
Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
November 2007, International journal of nursing studies,
Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
April 2021, Brain and behavior,
Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
December 2014, Nursing & health sciences,
Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
March 2022, Asian Pacific journal of cancer prevention : APJCP,
Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
July 2021, Medical journal, Armed Forces India,
Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
April 2022, Journal of cardiology,
Luke P Dawson, and Diem T Dinh, and Dion Stub, and Susannah Ahern, and Jason E Bloom, and Stephen J Duffy, and Jeffrey Lefkovits, and Angela Brennan, and Christopher M Reid, and Ernesto Oqueli, and
August 2020, Cancers,
Copied contents to your clipboard!